Summary:
A study to Evaluate the Efficacy, Safety, and Tolerability of the drug in treating patients with asthma on medium or high-dose inhaled corticosteroid.
Qualified Participants Must:
• Have A documented history of asthma for at least 1 year, with onset before age 40
•
Use of medium-dose ICS with or without a LABA or high-dose ICS alone for 3 months
Qualified Participants May Receive:
$75+ per completed in person visit.
Over $1,000 total reimbursement.